EN
中文 EN
Company News
Home >Newsroom >Company News
ALL
2025
2024
2023
2022
2021
2020
2019
2018
2016
2015
2014
2013
2012
2007
2025.02.24
CanSinoBIO Obtained Approval for Clinical Trials on DTcP-Hib-MCV4 Combined Vaccine
2025.02.07
CanSinoBIO Announces Priority Review Status for DTcP Infant
2025.02.06
CanSinoBIO Obtained Halal Decree of Menhycia® in Indonesia
2025.02.06
CanSinoBIO Received Acceptance of New Drug Application for its Tetanus Vaccine
2024.10.09
CanSinoBIO Secures Further Grant Funding
2024.06.25
CanSinoBIO Executives Talk with WHO Experts on the Development Progress of Polio Vaccines
2024.04.26
CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine
2024.03.25
CanSinoBIO Initiates Phase Ⅲ Clinical Trial of Group ACYW135 Meningococcal Conjugate Vaccine Menhycia® in Indonesia
2023.12.18
CanSinoBIO and SPIMACO Forge Strategic Partnership to Advance Accessibility of Cutting-Edge Vaccines
2023.12.04
CanSinoBIO Kicks-off the Polio VLP Vaccine Cooperation
1234568